Search results for “Cell stimulant” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 70 patents, we discovered top 23 key players by total patent application. Human Genome Sciences, Inc., Nektar Therapeutics, JSR Corp. are dominant in this area. They take 42.86% of the total patent filing.
Human Genome Sciences, Inc.
United States
Patent: 18
Nektar Therapeutics
California, United States
Patent: 6
JSR Corp.
Tokyo-to, Japan
Patent: 5
BioXcel Therapeutics, Inc.
Connecticut, United States
Patent: 5
Kite Pharma, Inc.
California, United States
Patent: 5
Yeda Research & Development Co. Ltd.
Israel
Patent: 5
Solco Basel AG
Switzerland
Patent: 2
Alpha X Biotech (Beijing) Co., Ltd.
Beijing Shi, China
Patent: 2
Sharp Corp.
Toyama-ken, Japan
Patent: 1
Biogen, Inc.
Massachusetts, United States
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 20 patents applied in the last 5 years. We discover 15 most active companies in this area. The fast-growing Nektar Therapeutics, BioXcel Therapeutics, Inc., Centre National De La Recherche Scientif take 80.00% of patent filing during this period.
Nektar Therapeutics
California, United States
Patent: 6
BioXcel Therapeutics, Inc.
Connecticut, United States
Patent: 5
Centre National De La Recherche Scientif
France
Patent: 5
Institut National de la Santé et de la Recherche Médicale
France
Patent: 5
Alpha X Biotech (Beijing) Co., Ltd.
Beijing Shi, China
Patent: 2
Seoul Semiconductor Co., Ltd.
South Korea
Patent: 1
Texas A&M University
Texas, United States
Patent: 1
Universidade Tiradentes
Sergipe, Brazil
Patent: 1
Universidade de Sorocaba
São Paulo, Brazil
Patent: 1
Washington University in St. Louis
Missouri, United States
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 20 patents in last 5 years, we discover 15 new entrants. Nektar Therapeutics, BioXcel Therapeutics, Inc., Centre National De La Recherche Scientif are the most active new entrants in this area.
Nektar Therapeutics
California, United States
Patent: 6
BioXcel Therapeutics, Inc.
Connecticut, United States
Patent: 5
Centre National De La Recherche Scientif
France
Patent: 5
Institut National de la Santé et de la Recherche Médicale
France
Patent: 5
Alpha X Biotech (Beijing) Co., Ltd.
Beijing Shi, China
Patent: 2
Seoul Semiconductor Co., Ltd.
South Korea
Patent: 1
Texas A&M University
Texas, United States
Patent: 1
Universidade Tiradentes
Sergipe, Brazil
Patent: 1
Universidade de Sorocaba
São Paulo, Brazil
Patent: 1
Washington University in St. Louis
Missouri, United States
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 23 patents, we discovered top 6 universities and scientific research institutions by total patent application. Texas A&M University, Washington University in St. Louis, Federal University of Rio de Janeiro are dominant in this area. They take 78.26% of the total patent filing.
Texas A&M University
Texas, United States
Patent: 1
Washington University in St. Louis
Missouri, United States
Patent: 1
Federal University of Rio de Janeiro
Rio de Janeiro, Brazil
Patent: 1
Chiba University
Chiba-ken, Japan
Patent: 1
Universidade Tiradentes
Sergipe, Brazil
Patent: 1
Universidade de Sorocaba
São Paulo, Brazil
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: